Extracellular Vesicles & Parkinson Disease

Extracellular vesicles found in human biological fluids may provide insight into the protein profiles of human neurons in various diseases, including Parkinson's disease. Here is the latest research on extracellular vesicles and Parkinson's disease.

December 1, 2021

Characterization and Chromatographic Isolation of Platelet Extracellular Vesicles from Human Platelet Lysates for Applications in Neuroregenerative Medicine.

ACS Biomaterials Science & Engineering
Ariunjargal Nyam-ErdeneThierry Burnouf
November 28, 2021
Review
Open Access

Extracellular Vesicles Physiological Role and the Particular Case of Disease-Spreading Mechanisms in Polyglutamine Diseases.

International Journal of Molecular Sciences
Ricardo MoreiraLuís Pereira de Almeida
November 17, 2021

Spontaneous Adenosine and Dopamine Cotransmission in the Caudate-Putamen Is Regulated by Adenosine Receptors.

ACS Chemical Neuroscience
Jason R BorgusB Jill Venton
November 15, 2021

α-Synuclein interacts differently with membranes mimicking the inner and outer leaflets of neuronal membranes.

Biochimica Et Biophysica Acta. Biomembranes
Samira JadaviSilvia Dante
November 9, 2021
Review
Open Access

Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases.

Frontiers in Aging Neuroscience
Tianbai LiWeidong Le
October 22, 2021
Review

Extracellular vesicle-associated small heat shock proteins as therapeutic agents in neurodegenerative diseases and beyond.

Advanced Drug Delivery Reviews
Bram Van den BroekJoy Irobi
October 13, 2021
Review
Open Access

Exosomes in Alzheimer's Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics.

International Journal of Molecular Sciences
Hagar M SolimanMohamed S Attia
September 30, 2021
Review
Open Access

Role of Exosomes in Brain Diseases.

Frontiers in Cellular Neuroscience
Nan ZhangLielian Zuo
September 18, 2021

Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion.

Cell Death & Disease
Qilin TangThomas Koeglsperger
September 16, 2021
Review

Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson's Disease.

Aging and Disease
L. LeggioNunzio Iraci
September 16, 2021
Review

Extracellular Vesicles for the Diagnosis and Treatment of Parkinson's Disease.

Aging and Disease
Raghavendra Upadhya, Ashok K Shetty
September 16, 2021
Comment / Editorial

Extracellular Vesicles in Health and Disease.

Aging and Disease
Ashok K Shetty, Raghavendra Upadhya
September 14, 2021

Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders.

Acta Neuropathologica
Marzena Kurzawa-AkanbiChristopher M Morris
September 4, 2021
Clinical Trial

Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Chen-Chih ChungChien-Tai Hong

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/extracellular-vesicles-parkinson/42776ae0-93dd-4bb6-82da-1b3444b2a34d